Ticker Details
Amneal Pharmaceuticals, Inc.
IPO Date:	January 1, 1900
Sector:	Healthcare
Industry:	Biotech
Market Cap:	$4.08B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.15 | 2.41%
Avg Daily Range (30 D):	$0.18 | 1.44%
Avg Daily Range (90 D):	$0.18 | 1.38%

Institutional Daily Volume
Avg Daily Volume:	.42M
Avg Daily Volume (30 D):	1.39M
Avg Daily Volume (90 D):	1.61M

Trade Size
Avg Trade Size (Sh.):	141
Avg Trade Size (Sh.) (30 D):	67
Avg Trade Size (Sh.) (90 D):	84

Institutional Trades
Total Institutional Trades:	2,025
Avg Institutional Trade:	$1.93M
Avg Institutional Trade (30 D):	$4.24M
Avg Institutional Trade (90 D):	$4.54M
Avg Institutional Trade Volume:	.2M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$2.25M
Avg Closing Trade (30 D):	$6.13M
Avg Closing Trade (90 D):	$7.06M
Avg Closing Volume:	238.32K

News

Feb 13, 2026 @ 4:26 PM Accessible Health Platforms Gain Scale Across $6T ... Source: Prnewswire

Jan 27, 2026 @ 11:02 PM TTM Technologies, Dutch Bros, Advanced Energy Indu... Source: Prnewswire

Dec 5, 2025 @ 1:00 PM Amneal Announces Positive Interim Phase 4 ELEVATE-... Source: Amneal Pharmaceuticals

Dec 2, 2025 @ 1:00 PM Amneal to Participate in Upcoming Investor Confere... Source: Anthony Dimeo

Oct 9, 2025 @ 1:31 PM Teva, Viatris On Investor Watch As White House Spa... Source: Vandana Singh

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$.23	$.11	$.23
Diluted EPS	$.22	$.11	$.22
Revenue	$3.02B	$814.32M	$3.02B
Gross Profit	$1.11B	$297.19M	$1.11B
Net Income / Loss	$127.93M	$49.57M	$127.93M
Operating Income / Loss	$394.1M	$112.03M	$394.1M
Cost of Revenue	$1.91B	$517.13M	$1.91B
Net Cash Flow	$194.52M	$74.53M	$194.52M
PE Ratio	57.00

Splits
Aug 26, 2013	1:25